liposomal glutathione parkinson& 39 Innovative approach in Parkinson's targeting via berberine-loaded mucoadhesive surface-modified liposomes: a multi-faceted study | BMC Pharmacology and Toxicology Dual-pathway targeted therapy for Parkinson's
Dual pathway targeted therapy for Parkinson's disease: Biomimetic nanosomes inhibit ferroptosis and pyroptosis through NLRP3 inflammasome regulation ScienceDirect Frontiers Recent advances in nanotechnology for Parkinson's disease: diagnosis, treatment, and future perspectives Research progress on intranasal treatment for Parkinson's disease Neuroprotection Frontiers Medicinefood homology bioactives in Parkinson's disease: multi target oxidative stress modulation and translation to dietary supplements
Pay in 4 interest-free payments of $6.53 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



